We performed the aforementioned analyses in a subgroup of AD patients that were both positive for AD-related amyloid and tau pathology according to the A/T/N system [21] to furtherly enhance the diagnostic accuracy and the homogeneity of the cohort. The gene discussed is MAPT; the disease is Alzheimer disease.